Thursday, Jul 7, 2022
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Business | Tagoor Laboratories Gets Dcgi Nod To Manufacture Favipiravir
Ads

Tagoor Laboratories gets DCGI nod to manufacture Favipiravir

By Telangana Today
Published: Published Date - 07:03 PM, Sun - 4 October 20
Tagoor Laboratories gets DCGI nod to manufacture Favipiravir
Favipiravir is a broad spectrum antiviral agent and selectively inhibits RNA polymerase of influenza virus and prevents viral replication Favipiravir is a broad spectrum antiviral agent and selectively inhibits RNA polymerase of influenza virus and prevents viral replication

Hyderabad: Hyderabad-based Tagoor Laboratories has received Drugs Controller General of India’s (DCGI’s) approval to manufacture Favipiravir. The active pharmaceutical ingredient (API) of the anti-viral drug has been approved for use in the treatment of mild to moderate Covid-19 cases.

Favipiravir is a broad spectrum antiviral agent and selectively inhibits RNA polymerase of influenza virus and prevents viral replication.

Commenting on obtaining the license, Dr P Kasi Viswanadha Raju, MD, said, “Tagoor Labs is capable of producing the drug without having to depend on any imports, as all the complex intermediates are developed in-house. Company aiming to manufacture Favipiravir in quantities sufficient to meet the growing domestic demand, which arose due to the pandemic.”

“Additionally, Tagoor Labs also manufactures and supplies Hydroxychloroquine sulphate, also used to treat Covid-19 symptoms. We have our R&D facility in Jeedimetla Industrial area, Hyderabad,” he added.

Tagoor Laboratories is in talks with the top buyers in the domestic market and is also making collaborations with various partners in Turkey, Iran, Egypt and Russia to supply Favipiravir bulk drug.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


 

  • Follow Us :
  • Tags
  • DCGI
  • Favipiravir
  • Hyderabad
  • Hyderabad Hardnews

Related News

  • Woman injured in road accident in Hyderabad

    Woman injured in road accident in Hyderabad

  • Ex-Andhra MLA escapes after police raid venue of cockfight near Hyderabad

    Ex-Andhra MLA escapes after police raid venue of cockfight near Hyderabad

  • Hyderabad: Balkampet temple festivities conclude

    Hyderabad: Balkampet temple festivities conclude

  • TSFDC working on long term plan to replace eucalyptus with sandalwood

    TSFDC working on long term plan to replace eucalyptus with sandalwood

  • Hyderabad: Man mowed down by truck near IKEA in Madhapur

    Hyderabad: Man mowed down by truck near IKEA in Madhapur

  • Hyderabad Sailing Week: Mohit, Gitesh tied for top spot

    Hyderabad Sailing Week: Mohit, Gitesh tied for top spot

Latest News

  • ‘Koffee With Karan’: Ranveer opens up on his relationship with in-laws

    4 mins ago
  • Punjab CM Bhagwant Mann to get married on Thursday

    8 mins ago
  • Shah Rukh Khan’s monochrome picture takes over the Internet

    13 mins ago
  • Wimbledon: Sania Mirza-Pavic pair suffer defeat against Skupski-Krawczyk

    19 mins ago
  • Naga Chaitanya’s touching ‘Thank You’ post makes his followers emotional

    34 mins ago
  • Man dies of cardiac arrest while having sex: Here’s what experts have to say

    48 mins ago
  • Wimbledon: Rafael Nadal survives five-set thriller

    1 hour ago
  • Elon Musk fathered twins with one of his executives in 2021: Report

    1 hour ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam